COMMUNIQUÉS West-GlobeNewswire

Sanofi : Le New England Journal of Medicine publie les résultats positifs de deux essais cliniques de phase III montrant que Dupixent® (dupilumab) améliore l'asthme modéré à sévère
21/05/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Le New England Journal of Medicine publie les résultats positifs de deux essais cliniques de phase III montrant que Dupixent ® (dupilumab) améliore l' [...]
UroGen Pharma Announces Positive Interim Results from Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
21/05/2018
Interim Results Showed Complete Response (CR) Rate of 59 Percent in Patients with Low-Grade UTUC CRs to Date Remain Durable at Three, Six and Nine-Month Follow-Up RA’ANANA, Israel and NEW YORK, May 21, 2018 (GLOBE [...]
Dova Pharmaceuticals Announces U.S. FDA Approval of DOPTELET® (avatrombopag)
21/05/2018
Company to Host Conference Call at 4:30 pm DURHAM, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced the U.S. Food and Drug Administration (FDA) has completed their [...]
Indiana Biosciences Research Institute names executive director of engagement, communications and external affairs
21/05/2018
INDIANAPOLIS, May 21, 2018 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Mark E. Craft as executive director of engagement, communications and external affairs [...]
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
21/05/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 21 MAY 2018 at 19.05 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]
Triangle Business Journal Awards Chiesi USA, Inc. Second Consecutive Corporate Philanthropy Award
21/05/2018
Chiesi in the Community impacts local organizations, communities, patients and employees CARY, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee ) , a specialty pharmaceutical company based in Cary, N.C., [...]
Initial Data from Profound Medical’s TACT Pivotal Clinical Trial Presented at AUA 2018
21/05/2018
TORONTO, May 21, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Milestone Scientific Announces Three Additional Independent Distributors in the U.S. for CompuFlo® Epidural System
21/05/2018
Agreements cover territories within the Pacific Northwest, Southeast and Midwest Reports growing interest following successful showing at The SOAP 50th Annual Meeting LIVINGSTON, N.J., May 21, 2018 (GLOBE NEWSWIRE) -- [...]
Cerner Announces Amendment to Share Repurchase Program
21/05/2018
KANSAS CITY, Mo., May 21, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced that its board of directors approved an amendment to its stock repurchase program on May 17, 2018, at its regularly [...]
Letter to Shareholders from ACOL CEO Curt Fairbrother: May 21, 2018
21/05/2018
CORONA, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Dear Shareholders: Many of you have been following our company since its inception in 2013 and have seen the steady growth that we have achieved in that time. Our most [...]
NuvusGro (NUVG) Introduces the Nuvus Mobile Mining Unit (MoMu) Utilizing its Grow.Droid Enterprise Technology – MoMu to Mine Bitcoin, Ether, BCH, and Altcoins
21/05/2018
Saint Petersburg, FL, May 21, 2018 (GLOBE NEWSWIRE) -- NuvusGro Corp. (OTC PINK: NUVG), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the [...]
Stanford Researchers Presented Results from an Exploratory Study of Serlopitant for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients Indicating Reduction in Itch with Serlopitant Treatment
21/05/2018
Results Presented at the International Investigative Dermatology Meeting REDWOOD CITY, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on [...]
Terveystalo Plc: Managers' Transactions
21/05/2018
TERVEYSTALO PLC MANAGERS' TRANSACTIONS 21 May 2018 at 15:15 EEST ____________________________________________ Person subject to the notification requirement Name: HC TT Holding Oy Ab (Hartwall Capital) Position: Closely [...]
Allscripts closes acquisition of HealthGrid
21/05/2018
Company expands its FollowMyHealth® consumer engagement platform with advanced capabilities CHICAGO, May 21, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ), a global leader in healthcare technology, today announces [...]
Terveystalo Plc: Managers' Transactions
21/05/2018
TERVEYSTALO PLC MANAGERS' TRANSACTIONS 21 May 2018 at 15:00 EEST ____________________________________________ Person subject to the notification requirement Name: Heinonen, Lasse Position: Member of the Board/Deputy [...]
MimiVax Announces Positive Interim Results from Phase II Trial of SurVaxM Immunotherapy for the Treatment of Newly Diagnosed Glioblastoma
21/05/2018
Interim analysis shows significant survival benefit compared to historical standard of care; Combination of SurVaxM and standard therapy was well-tolerated, with few serious side effects; MimiVax to share findings at [...]
Athenex to Present at UBS Global Healthcare Conference
21/05/2018
BUFFALO, N.Y., May 21, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the American Association of Critical-Care Nurses Exposition May 22-24
21/05/2018
Caregiver does not come into contact with the patient’s skin nor require probe covers, reducing the risk of cross-contamination and eliminating unnecessary costs DELRAY BEACH, Fla., May 21, 2018 (GLOBE NEWSWIRE) -- [...]
Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration
21/05/2018
First-in-Class Antibody-Drug Conjugate had Received Prior Breakthrough Therapy Designation from the FDA for the Treatment of Metastatic Triple-Negative Breast Cancer MORRIS PLAINS, N.J., May 21, 2018 (GLOBE NEWSWIRE [...]

Pages